Industrial Policy for the United States seeks to list all of the tools a country can use to improve its industrial base and entice businesses to invest in manufacturing. If these tools are deployed, the authors argue, the results will be good for local economies and labor.
The duties impact several major Chinese solar brands, including Jinko Solar and Trina Solar, as well as Vietnamese manufacturers that Commerce believes have been circumventing tariffs by importing components from mainland China for final assembly.
Varoufakis’ essay is a must-read for CPA members curious about what a former G-20 Finance Minister (the equivalent of our Treasury Secretary) thinks about the dollar.
President Trump released his “Fair and Reciprocal Trade” memo on Thursday, calling into question whether these new proposed tariffs will be permanent like the China Section 301s or quickly removed once a country “reciprocates” in kind.
The evidence is clear: neither tariffs nor the surge of imports from trade liberalization have had a significant effect on inflation, positive or negative.
It’s the most well-known secret on Capitol Hill: China owns the American generic drug supply chain. Basic thyroid or blood pressure medications might finally be put into pill form in an Indian lab and sold under an Indian brand like Cipla. But the organic compounds, or key starting materials, mostly come from China.
China is forecast to account for 45% of the world’s global industrial production by 2030. That growth comes at the expense of the West, which is projected to drop to 11% of global production in the next five years.
Despite Section 232 global steel tariffs and quotas on European raw steel, imports of steel slabs and steel products like steel rebar are up. The surge is eating into domestic producer market share, and companies are closing shop.
America’s steel industry supports millions of American workers and is the backbone of critical industries. By imposing tariffs on steel imports and its derivatives, Trump can restore America’s industrial strength and secure a prosperous future for workers.
Jamieson Greer seems certain to be approved as the next United States Trade Representative (USTR), but the Democrats on the Senate Finance Committee proved once again that they are anti-tariff—unless the target is China.
Notifications